Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 787

1.

Screening guidelines and recommendations for patients at high risk of developing endocrine cancers.

Geurts JL, Strong EA, Wang TS, Evans DB, Clarke CN.

J Surg Oncol. 2020 Feb 23. doi: 10.1002/jso.25869. [Epub ahead of print] Review.

PMID:
32090344
2.

Role of Molecular Profiling of Pancreatic Cancer After Neoadjuvant Therapy: Does it Change Practice?

Krepline AN, Bliss L, Geurts J, Akinola I, Christians KK, George B, Ritch PS, Hall WA, Erickson BA, Evans DB, Tsai S.

J Gastrointest Surg. 2020 Feb;24(2):235-242. doi: 10.1007/s11605-019-04423-6. Epub 2019 Nov 19.

PMID:
31745905
3.

Management of Acute Cholecystitis during Neoadjuvant Therapy in Patients with Pancreatic Adenocarcinoma.

Jariwalla NR, Khan AH, Dua K, Christians KK, Clarke CN, Aldakkak M, George B, Tutton S, Rilling W, Erickson B, Evans DB, Tsai S.

Ann Surg Oncol. 2019 Dec;26(13):4515-4521. doi: 10.1245/s10434-019-07906-7. Epub 2019 Oct 22.

PMID:
31641946
4.

Persistent/Recurrent Primary Hyperparathyroidism: Does the Number of Abnormal Glands Play a Role?

Mazotas IG, Yen TWF, Doffek K, Shaker JL, Carr AA, Evans DB, Wang TS.

J Surg Res. 2020 Feb;246:335-341. doi: 10.1016/j.jss.2019.08.007. Epub 2019 Oct 18.

PMID:
31635835
5.

Continuity With Patients, Preceptors, and Peers Improves Primary Care Training: A Randomized Medical Education Trial.

Henschen BL, Liss DT, Golden BP, Cameron KA, Bierman JA, Ryan ER, Gard LA, Neilson EG, Wayne DB, Evans DB.

Acad Med. 2020 Mar;95(3):425-434. doi: 10.1097/ACM.0000000000003045.

PMID:
31626000
6.

Confirmation of Parathyroid Tissue: Are Surgeons Aware of New and Novel Techniques?

Coan KE, Yen TWF, Carr AA, Evans DB, Wang TS.

J Surg Res. 2020 Feb;246:139-144. doi: 10.1016/j.jss.2019.08.006. Epub 2019 Sep 27.

PMID:
31569035
7.

Goals of Treatment Sequencing for Localized Pancreatic Cancer.

Evans DB, Kamgar M, Tsai S.

Ann Surg Oncol. 2019 Nov;26(12):3815-3819. doi: 10.1245/s10434-019-07738-5. Epub 2019 Sep 6. No abstract available.

PMID:
31493126
8.

Perioperative Gemcitabine + Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial.

Wei AC, Ou FS, Shi Q, Carrero X, O'Reilly EM, Meyerhardt J, Wolff RA, Kindler HL, Evans DB, Deshpande V, Misdraji J, Tamm E, Sahani D, Moore M, Newman E, Merchant N, Berlin J, Goff LW, Pisters P, Posner MC.

Ann Surg Oncol. 2019 Dec;26(13):4489-4497. doi: 10.1245/s10434-019-07685-1. Epub 2019 Aug 15.

PMID:
31418130
9.

Continuity in Undergraduate Medical Education: Mission Not Accomplished.

Evans DB, Henschen BL, Poncelet AN, Wilkerson L, Ogur B.

J Gen Intern Med. 2019 Oct;34(10):2254-2259. doi: 10.1007/s11606-019-04949-0.

PMID:
31346908
10.

Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgery.

Barnes CA, Chavez MI, Tsai S, Aldakkak M, George B, Ritch PS, Dua K, Clarke CN, Tolat P, Hagen C, Hall WA, Erickson BA, Evans DB, Christians KK.

Surgery. 2019 Sep;166(3):277-285. doi: 10.1016/j.surg.2019.05.010. Epub 2019 Jul 2.

PMID:
31272811
11.

Editorial: Small, asymptomatic, nonfunctioning pancreatic neuroendocrine tumors: Observation becoming standard of care?

Clarke CN, Evans DB.

Surgery. 2019 Aug;166(2):164-165. doi: 10.1016/j.surg.2019.03.017. Epub 2019 May 13. No abstract available.

PMID:
31097321
12.

Distal splenorenal and mesocaval shunting at the time of pancreatectomy.

Chavez MI, Tsai S, Clarke CN, Aldakkak M, Griffin MO, Khan AH, Ritch PS, Erickson BA, Evans DB, Christians KK.

Surgery. 2019 Feb;165(2):298-306. doi: 10.1016/j.surg.2018.10.008. Epub 2018 Nov 22.

PMID:
30471779
13.

Importance of Normalization of CA19-9 Levels Following Neoadjuvant Therapy in Patients With Localized Pancreatic Cancer.

Tsai S, George B, Wittmann D, Ritch PS, Krepline AN, Aldakkak M, Barnes CA, Christians KK, Dua K, Griffin M, Hagen C, Hall WA, Erickson BA, Evans DB.

Ann Surg. 2018 Oct 11. doi: 10.1097/SLA.0000000000003049. [Epub ahead of print]

PMID:
30312198
14.

What Makes a Pancreatic Cancer Resectable?

Evans DB.

Am Soc Clin Oncol Educ Book. 2018 May 23;38:300-305. doi: 10.1200/EDBK_200861. Review.

15.

Patients with Oncocytic Variant Papillary Thyroid Carcinoma Have a Similar Prognosis to Matched Classical Papillary Thyroid Carcinoma Controls.

Carr AA, Yen TWF, Ortiz DI, Hunt BC, Fareau G, Massey BL, Campbell BH, Doffek KL, Evans DB, Wang TS.

Thyroid. 2018 Nov;28(11):1462-1467. doi: 10.1089/thy.2017.0603.

PMID:
30215297
16.

Learning to be a doctor: Medical students' perception of their roles in longitudinal outpatient clerkships.

Golden BP, Henschen BL, Gard LA, Ryan ER, Evans DB, Bierman J, Cameron KA.

Patient Educ Couns. 2018 Nov;101(11):2018-2024. doi: 10.1016/j.pec.2018.08.003. Epub 2018 Aug 2.

PMID:
30122264
17.

A Phase II Clinical Trial of Molecular Profiled Neoadjuvant Therapy for Localized Pancreatic Ductal Adenocarcinoma.

Tsai S, Christians KK, George B, Ritch PS, Dua K, Khan A, Mackinnon AC, Tolat P, Ahmad SA, Hall WA, Erickson BA, Evans DB.

Ann Surg. 2018 Oct;268(4):610-619. doi: 10.1097/SLA.0000000000002957.

PMID:
30080723
18.

A postoperative parathyroid hormone-based algorithm to reduce symptomatic hypocalcemia following completion/total thyroidectomy: A retrospective analysis of 591 patients.

Mazotas IG, Yen TWF, Park J, Liu Y, Eastwood DC, Carr AA, Evans DB, Wang TS.

Surgery. 2018 Oct;164(4):746-753. doi: 10.1016/j.surg.2018.04.040. Epub 2018 Jul 30.

PMID:
30072256
19.

Decreased trend in hospital mortality from pancreatic cancer despite increase in number of hospital admissions.

Bhandari S, Abdul MKM, Hollabaugh W, Sharma K, Evans DB, Guda N.

PLoS One. 2018 Jul 18;13(7):e0199909. doi: 10.1371/journal.pone.0199909. eCollection 2018.

20.

Genotoxicity of flubendazole and its metabolites in vitro and the impact of a new formulation on in vivo aneugenicity.

Tweats DJ, Johnson GE, Scandale I, Whitwell J, Evans DB.

Mutagenesis. 2018 Sep 17;33(3):263-266. doi: 10.1093/mutage/gey006. No abstract available.

21.

Perceptions of Patient-Centered Care among First-Year Medical Students.

Henschen BL, Ryan ER, Evans DB, Truong A, Wayne DB, Bierman JA, Cameron KA.

Teach Learn Med. 2019 Jan-Mar;31(1):26-33. doi: 10.1080/10401334.2018.1468260. Epub 2018 May 30.

PMID:
29847155
22.

Molecular evaluation of a sporadic paraganglioma with concurrent IDH1 and ATRX mutations.

Zhang J, Jiang J, Luo Y, Li X, Lu Z, Liu Y, Huang J, Hou Y, Pang Y, Sun MYF, Wang TS, Evans DB, Pacak K, Zhuang Z, Gao X.

Endocrine. 2018 Aug;61(2):216-223. doi: 10.1007/s12020-018-1617-1. Epub 2018 May 30.

PMID:
29846902
23.

Prophylactic Central Compartment Neck Dissection in Papillary Thyroid Cancer and Effect on Locoregional Recurrence.

Hughes DT, Rosen JE, Evans DB, Grubbs E, Wang TS, Solórzano CC.

Ann Surg Oncol. 2018 Sep;25(9):2526-2534. doi: 10.1245/s10434-018-6528-0. Epub 2018 May 21.

PMID:
29786126
24.

Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models.

Tsai S, McOlash L, Palen K, Johnson B, Duris C, Yang Q, Dwinell MB, Hunt B, Evans DB, Gershan J, James MA.

BMC Cancer. 2018 Mar 27;18(1):335. doi: 10.1186/s12885-018-4238-4.

25.

Thyroid cancer in adolescents and young adults.

Massimino M, Evans DB, Podda M, Spinelli C, Collini P, Pizzi N, Bleyer A.

Pediatr Blood Cancer. 2018 Aug;65(8):e27025. doi: 10.1002/pbc.27025. Epub 2018 Mar 12. Review.

PMID:
29528191
26.

Locally advanced pancreas cancer: Staging and goals of therapy.

Chatzizacharias NA, Tsai S, Griffin M, Tolat P, Ritch P, George B, Barnes C, Aldakkak M, Khan AH, Hall W, Erickson B, Evans DB, Christians KK.

Surgery. 2018 May;163(5):1053-1062. doi: 10.1016/j.surg.2017.09.012. Epub 2018 Jan 10.

PMID:
29331400
27.

Characterizing indeterminate liver lesions in patients with localized pancreatic cancer at the time of diagnosis.

Bhalla M, Aldakkak M, Kulkarni NM, O'Connor SD, Griffin MO Jr, Christians KK, Evans DB, Tsai S, Tolat PP.

Abdom Radiol (NY). 2018 Feb;43(2):351-363. doi: 10.1007/s00261-017-1404-0.

PMID:
29185014
28.

A Multi-institutional Comparison of Adrenal Venous Sampling in Patients with Primary Aldosteronism: Caution Advised if Successful Bilateral Adrenal Vein Sampling is Not Achieved.

Wang TS, Kline G, Yen TW, Yin Z, Liu Y, Rilling W, So B, Findling JW, Evans DB, Pasieka JL.

World J Surg. 2018 Feb;42(2):466-472. doi: 10.1007/s00268-017-4327-6.

PMID:
29124355
29.

Development of a high risk pancreatic screening clinic using 3.0 T MRI.

Barnes CA, Krzywda E, Lahiff S, McDowell D, Christians KK, Knechtges P, Tolat P, Hohenwalter M, Dua K, Khan AH, Evans DB, Geurts J, Tsai S.

Fam Cancer. 2018 Jan;17(1):101-111. doi: 10.1007/s10689-017-0057-z.

PMID:
29101607
30.

Taking health systems research syntheses to the next level: overviews of systematic reviews.

Ranson MK, Evans DB.

Cochrane Database Syst Rev. 2017 Sep 13;9:ED000123. doi: 10.1002/14651858.ED000123. No abstract available.

PMID:
28975617
31.

Should functional renal scans be obtained prior to upper abdominal IMRT for pancreatic cancer?

Blitzer GC, Hall WA, Tsai S, Aldakkak M, Hellman RS, Evans DB, Christians KK, George B, Ritch PS, Erickson BA.

Pract Radiat Oncol. 2017 Nov - Dec;7(6):e449-e455. doi: 10.1016/j.prro.2017.06.013. Epub 2017 Jun 29.

PMID:
28886941
32.

Is Adjuvant Therapy Necessary for All Patients with Localized Pancreatic Cancer Who Have Received Neoadjuvant Therapy?

Barnes CA, Krepline AN, Aldakkak M, Clarke CN, Christians KK, Khan AH, Hunt BC, Ritch PS, George B, Hall WA, Erickson BA, Evans DB, Tsai S.

J Gastrointest Surg. 2017 Nov;21(11):1793-1803. doi: 10.1007/s11605-017-3544-5. Epub 2017 Aug 28.

PMID:
28849366
33.

Disparities in access to care and outcomes in patients with adrenocortical carcinoma.

Hammad AY, Yen TWF, Carr AA, Evans DB, Wang TS.

J Surg Res. 2017 Jun 1;213:138-146. doi: 10.1016/j.jss.2017.02.046. Epub 2017 Mar 3.

PMID:
28601306
34.

Concurrent endocrine and other surgical procedures: an institutional experience.

Morris R, Yen TWF, Doffek K, Carr AA, Wilson SD, Evans DB, Wang TS.

J Surg Res. 2017 May 1;211:107-113. doi: 10.1016/j.jss.2016.12.013. Epub 2016 Dec 22.

PMID:
28501106
35.

A Novel Reconstruction Technique During Pancreaticoduodenectomy After Roux-En-Y Gastric Bypass: How I do It.

Younan G, Tsai S, Evans DB, Christians KK.

J Gastrointest Surg. 2017 Jul;21(7):1186-1191. doi: 10.1007/s11605-017-3405-2. Epub 2017 Apr 26.

36.

Towards a coherent global framework for health financing: recommendations and recent developments.

Ottersen T, Elovainio R, Evans DB, McCoy D, Mcintyre D, Meheus F, Moon S, Ooms G, Røttingen JA.

Health Econ Policy Law. 2017 Apr;12(2):285-296. doi: 10.1017/S1744133116000505.

37.

Raising more domestic money for health: prospects for low- and middle-income countries.

Elovainio R, Evans DB.

Health Econ Policy Law. 2017 Apr;12(2):139-157. doi: 10.1017/S1744133116000426.

PMID:
28332458
38.

Global health financing towards 2030 and beyond.

Ottersen T, Evans DB, Mossialos E, Røttingen JA.

Health Econ Policy Law. 2017 Apr;12(2):105-111. doi: 10.1017/S1744133116000372. No abstract available.

PMID:
28332454
39.

Cancer cell chemokines direct chemotaxis of activated stellate cells in pancreatic ductal adenocarcinoma.

Roy I, Boyle KA, Vonderhaar EP, Zimmerman NP, Gorse E, Mackinnon AC, Hwang RF, Franco-Barraza J, Cukierman E, Tsai S, Evans DB, Dwinell MB.

Lab Invest. 2017 Mar;97(3):302-317. doi: 10.1038/labinvest.2016.146. Epub 2017 Jan 16.

40.

Using parathyroid hormone spikes during parathyroidectomy to guide intraoperative decision-making.

Carr AA, Yen TW, Wilson SD, Evans DB, Wang TS.

J Surg Res. 2017 Mar;209:162-167. doi: 10.1016/j.jss.2016.10.006. Epub 2016 Oct 14.

PMID:
28032553
41.

Poor Glycemic Control Is Associated with Failure to Complete Neoadjuvant Therapy and Surgery in Patients with Localized Pancreatic Cancer.

Rajamanickam ES, Christians KK, Aldakkak M, Krepline AN, Ritch PS, George B, Erickson BA, Foley WD, Aburajab M, Evans DB, Tsai S.

J Gastrointest Surg. 2017 Mar;21(3):496-505. doi: 10.1007/s11605-016-3319-4. Epub 2016 Nov 28.

PMID:
27896658
42.

Parathyroidectomy for primary hyperparathyroidism improves sleep quality: A prospective study.

La J, Wang TS, Hammad AY, Burgardt L, Doffek K, Carr AA, Shaker JL, Carroll TB, Evans DB, Yen TW.

Surgery. 2017 Jan;161(1):25-34. doi: 10.1016/j.surg.2016.05.047. Epub 2016 Nov 16.

PMID:
27865592
43.

Techniques of Vascular Resection and Reconstruction in Pancreatic Cancer.

Younan G, Tsai S, Evans DB, Christians KK.

Surg Clin North Am. 2016 Dec;96(6):1351-1370. doi: 10.1016/j.suc.2016.07.005. Epub 2016 Oct 14. Review.

PMID:
27865282
44.

Multimodality Therapy in Patients With Borderline Resectable or Locally Advanced Pancreatic Cancer: Importance of Locoregional Therapies for a Systemic Disease.

Tsai S, Christians KK, Ritch PS, George B, Khan AH, Erickson B, Evans DB.

J Oncol Pract. 2016 Oct;12(10):915-923. Review. Erratum in: J Oncol Pract. 2017 Mar;13(3):216.

PMID:
27858562
45.

Commentary on: Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.

Wang TS, Evans DB.

Surgery. 2017 Feb;161(2):472-474. doi: 10.1016/j.surg.2016.09.019. Epub 2016 Nov 9. No abstract available.

PMID:
27836215
46.

Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience.

Cloyd JM, Katz MH, Prakash L, Varadhachary GR, Wolff RA, Shroff RT, Javle M, Fogelman D, Overman M, Crane CH, Koay EJ, Das P, Krishnan S, Minsky BD, Lee JH, Bhutani MS, Weston B, Ross W, Bhosale P, Tamm EP, Wang H, Maitra A, Kim MP, Aloia TA, Vauthey JN, Fleming JB, Abbruzzese JL, Pisters PW, Evans DB, Lee JE.

J Gastrointest Surg. 2017 Jan;21(1):164-174. doi: 10.1007/s11605-016-3265-1. Epub 2016 Oct 24.

PMID:
27778257
47.

Venous thromboembolism prophylaxis during neoadjuvant therapy for resectable and borderline resectable pancreatic cancer-Is it indicated?

Krepline AN, Christians KK, George B, Ritch PS, Erickson BA, Tolat P, Evans DB, Tsai S.

J Surg Oncol. 2016 Oct;114(5):581-586. doi: 10.1002/jso.24361. Epub 2016 Oct 19.

PMID:
27760280
48.

Evolution of the Management of Resectable Pancreatic Cancer.

Tsai S, Erickson BA, Dua K, Ritch PS, Tolat P, Evans DB.

J Oncol Pract. 2016 Sep;12(9):772-8. doi: 10.1200/JOP.2016.015818. Review.

PMID:
27621326
49.

Neoadjuvant therapy versus upfront surgical strategies in resectable pancreatic cancer: A Markov decision analysis.

de Geus SW, Evans DB, Bliss LA, Eskander MF, Smith JK, Wolff RA, Miksad RA, Weinstein MC, Tseng JF.

Eur J Surg Oncol. 2016 Oct;42(10):1552-60. doi: 10.1016/j.ejso.2016.07.016. Epub 2016 Aug 9.

PMID:
27570116
50.

Intraoperative ex vivo parathyroid aspiration: A point-of-care test to confirm parathyroid tissue.

Coan KE, Yen TWF, Carr AA, Bullock M, Colon-Franco JM, Evans DB, Wang TS.

Surgery. 2016 Oct;160(4):850-857. doi: 10.1016/j.surg.2016.06.036. Epub 2016 Aug 18.

PMID:
27545996

Supplemental Content

Loading ...
Support Center